GlassScriptPhysician profile
Melissa A Craft
NPI 1346550787
$2,576.48
in general payments reported to CMS, 2019-2025
12 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Oncology (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $263).
See the full distribution for Oncology (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $488 · 2022: $400 · 2023: $709 · 2024: $683 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.52 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $639.67 | 2021-2024 | Opdivo, Pomalyst |
| Astrazeneca Pharmaceuticals LP | $481.75 | 2021-2024 | Tagrisso, Enhertu |
| Jazz Pharmaceuticals INC. | $327.06 | 2023-2025 | Vyxeos, Zepzelca |
| Seagen INC. | $206.51 | 2021-2023 | Adcetris |
| Astellas Pharma US INC | $201.92 | 2022-2023 | |
| Glaxosmithkline, LLC. | $124.84 | 2025 | Zejula |
| Eisai INC. | $118.45 | 2024 | |
| Celgene Corporation | $109.29 | 2021 | |
| Medtronic, INC. | $105.51 | 2024 | Aurora Ev-Icd Mri Surescan |
| Amgen INC. | $101.93 | 2021 | |
| Abbott Laboratories | $83.77 | 2022 | |
| Tempus Ai, INC | $75.78 | 2025 | Xt Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Craft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.